Sex differences in regulatory cells in experimental stroke

Hilary A. Seifert, Gil Benedek, Jian Liang, Ha Nguyen, Gail Kent, Arthur Vandenbark, Julie Saugstad, Halina Offner

Research output: Contribution to journalArticle

9 Scopus citations


Stroke is the leading cause of disability in the United States. Sex differences, including smaller infarcts in females and greater involvement of immune-mediated inflammation in males may affect the efficacy of immune-modulating interventions. To address these differences, we sought to identify distinct stroke-modifying mechanisms in female vs. male mice. The current study demonstrated smaller infarcts and increased levels of regulatory CD19+CD5+CD1dhi B10 cells as well as anti-inflammatory CD11b+CD206+ microglia/macrophages in the ipsilateral vs. contralateral hemisphere of female but not male mice undergoing 60min middle cerebral artery occlusion followed by 96h of reperfusion. Moreover, female mice with MCAO had increased total spleen cell numbers but lower B10 levels in spleens. These results elucidate differing sex-dependent regulatory mechanisms that account for diminished stroke severity in females and underscore the need to test immune-modulating therapies for stroke in both males and females.

Original languageEnglish (US)
JournalCellular Immunology
StateAccepted/In press - May 23 2017


  • Anti-inflammatory macrophages
  • Lymphocyte
  • Middle cerebral artery occlusion
  • Regulatory B cells
  • Regulatory T cells
  • Sex-specific

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Sex differences in regulatory cells in experimental stroke'. Together they form a unique fingerprint.

  • Cite this